Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Bariatric Surgeons

Council Members in this Study Group: 195

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Howard Beaton

Associate Professor of Surgery
Mount Sinai Medical Center (NY)
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Howard Beaton, MD, is an Attending Surgeon and Associate Professor of Surgery at the Mount Sinai Medical Center in New York City. Previously, he was the Chairman of Surgery at North General and NYU Downtown Hospitals. Dr. Beaton has over 25 years of experience...

Elliot Goodman, Chief of Bariatric Surgery, BETH ISRAEL MEDICAL CENTER (INC)Elliot Goodman

Chief of Bariatric Surgery
BETH ISRAEL MEDICAL CENTER (INC)
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Elliot Goodman, MD, is Chief of Bariatric Surgery at Beth Israel Medical Center and Assistant Professor of Surgery at Albert Einstein College of Medicine in New York City. His main clinical interest is bariatric surgery. His research interests include...

Michael Bain

Plastic and Reconstructive Physician
Michael A Bain, MD
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Michael Bain, MD, MS, is a Plastic and Reconstructive Physician in private practice based in Southern California. He has experience in all areas of plastic and reconstructive surgery including bariatric, breast, cosmetic, and reconstructive surgery. Dr....

Michael Salzhauer, Chief Surgeon, Bal Harbour Plastic Surgery AssociatesMichael Salzhauer

Chief Surgeon
Bal Harbour Plastic Surgery Associates
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Michael Salzhauer, MD, is the Chief Surgeon at Bal Harbour Plastic Surgery Associates, a plastic surgery private practice based in Florida. He has extensive expertise in all aspects of cosmetic surgery, including breast surgery augmentation, reduction,...

Forrest Rubenstein

Cardiac, Thoracic and Vascular Surgeon
Rubenstein Cardiovascular and Thoracic Surgery
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Forrest Rubenstein, MD, FACS, is a Cardiac, Thoracic and Vascular Surgeon in private practice. Dr. Rubenstein is board certified in General, Cardiovascular and Thoracic Surgery. He has experience in cardiac, thoracic and vascular surgery, aortic surgery,...

GLG NewsSM Analyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Preventing Bariatric Surgery Deaths

January 25, 2008

Pinning Down Mortality Rates After Bariatric Surgery | www.medscape.com

 Bariatric surgery is a major operative procedure that caries significant morbidity and mortality risks due to the comorbid diseases seen in this patient population.  This procedure is increasing in frequency as more patients are willing to have it and more surgeons are becoming proficient. The mortality rate is ~ 1 % at 1 year and 6% at 5 years which is greater than the population at large.

CMS regulations penalize hospitals for taking care of sickest patients

August 28, 2007

New Medicare Regulations Adopted To Reduce Certain Hospital Infections And Medical Errors | www.medicalnewstoday.com

This article presents the new CMS guidelines that deny higher payments for the additional costs associated with treating patients for certain hospital - acquired infections and medical errors. While these are laudable goals, to assume that all infections are the result of poor medical practice is an oversimplification. The development of nosocomial infections also has to do with the patients disease processes such as diabetes, morbid obesity, immunosuppression, tobacco abuse, etc. While few physicians would argue against enforcing these rules for documented mistakes (medication errors, transfusion mistakes, and objects left in patients bodies), most recognize there is a certain baseline of these other infections which cannot be avoided. Hospitals should only be penalized when their risk adjusted incidence exceeds a standardized baseline.

Retail drugstore clinics - filling a niche ?

August 28, 2007

Drugstore Clinics Spread, and Scrutiny Grows | www.nytimes.com

   Several large drugstores are establishing retail medical clinics within their stores much as eyeglass stores have had optomitrists on site.  There is no problem with these clinics per se as long as they practice within the scope of the practitioners license and skill.  There are concerns that those clinics staffed by non physicians will be practicing inferior medicine beyond the scope of the practitioner.  As these clinics become more widespread, they will certainly come under greater scrutiny.

This coud ne a Panora's Box

August 28, 2007

New Medicare Regulations Adopted To Reduce Certain Hospital Infections And Medical Errors | www.medicalnewstoday.com

If a patient gets a bedsore, who pays for it? Most importantly, what does this mean to KCI and the other wound companies? Where will it end?

The drug patent "shell game"

August 28, 2007

New antihistamine gets FDA green light.(RX CARE)(Levocetirizine (Xyzal) by UCB Inc. and Sanofi-Aventis ) | www.therapeuticsdaily.com

   Zyrtec (cetirizine) is a second generation nonsedating antihistamine that has enjoyed wide popularity.  Zyrtec will become available generically in late 2007 and the generic form is expected to be significantly cheaper.  To virtually extend the patent, the manufacturer is marketing the active enantiomer, levocitirizine (Xyzal) as a replacement for Zyrtec. This required only a fraction of the R&D costs that developing a new drug would entail.  While this could be a boon to the pharmaceutical companies involved in the release, patients have little to benefit from the increased cost.

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Free-standing Surgery Center

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Division Head
  • Owner
  • Director
  • President